Substance
LIGELIZUMAB
Global reference: every product and company linked to this substance.
- cas: 1322627-61-1
- ncit: C175809
- unii: L8LE0L691T
ligelizumab [INN] · LIGELIZUMAB [JAN] · LIGELIZUMAB [USAN] · Ligelizumab [WHO-DD] · QGE-031 · QGE031
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.